Role of UCHL1 in Axonal Injury and Recovery after TBI
UCHL1 在 TBI 后轴突损伤和恢复中的作用
基本信息
- 批准号:10199060
- 负责人:
- 金额:$ 40.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-01 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAmyloid beta-Protein PrecursorAnimal ModelAutophagocytosisAxonAxonal TransportBehaviorBinding SitesBlood - brain barrier anatomyBrainCapsid ProteinsCell DeathCerebral IschemiaCerebrumChimeric ProteinsClinical TrialsCognitiveCognitive deficitsCysteineCytoskeletonDataDiffuse Axonal InjuryDoseEnzymesExcisionGoalsHalf-LifeHippocampus (Brain)HistologicHydrolaseIn VitroInjuryKnock-in MouseKnowledgeLaboratoriesLipid BindingLipidsLong-Term PotentiationMechanicsMediatingMemoryModelingMolecularMotorMusMutationNeuronsOutcomePathway interactionsPatientsPermeabilityPlayProcessProteinsRecoveryRecovery of FunctionResistanceRoleSiteStretchingTBI treatmentTestingTrans-ActivatorsTranscription CoactivatorTranslatingTraumatic Brain InjuryTraumatic Brain Injury recoveryUbiquitinWild Type Mouseaxon injurybehavioral outcomecognitive functioncontrolled cortical impactdesignimmunocytochemistryimprovedimproved outcomein vivoinjury recoveryinsightmotor behaviormotor deficitmotor function improvementmulticatalytic endopeptidase complexneuron lossnovelnovel strategiespreservationpreventrepairedrestorationsafety and feasibilityselective expressionsynaptic functiontat Proteintreatment strategyubiquitin C-terminal hydrolase
项目摘要
Diffuse axonal injury is a major component of the motor and cognitive sequela of
traumatic brain injury (TBI). Ubiquitin C-terminal hydrolase L1 (UCHL1) is expressed at high
concentrations in neurons and may play an important role axonal transport and synaptic
function. UCHL1's activity is important in degrading abnormal neuronal protein via the ubiquitin
proteasome pathway. Thus, UCHL1 may play an important role in recovery after injury via
several mechanisms. In preliminary studies, a TAT-UCHL1 protein was constructed that readily
enters the brain when given i.p. Treatment with TAT-UCHL1 reduced axonal injury detected by
APP immunocytochemistry and decreased hippocampal cell death after controlled cortical
impact (CCI) in mice. A reactive lipid binding site at the 152 cysteine of UCHL1 was identified
that is responsible for unfolding and inactivating the enzyme. A knock-in mouse bearing a
C152A mutation was constructed and found to have significantly reduced axonal injury and
improved motor behavior after CCI. A mouse bearing a C90A mutation with UCHL1 activity that
is devoid of hydrolase activity was also constructed.
The goals of the current study are: 1) Determine the role of the UCHL1 C152 site in
axonal injury, neuronal death, and motor and cognitive behavior after CCI in mice. 2)
Determine the role of UCHL1 hydrolase activity in axonal injury, neuronal death, and
motor and cognitive behavior after CCI in mice. 3) Test whether systemic treatment with
TAT-UCHL1 fusion proteins will reduce axonal injury in the in vitro stretch model and in
vivo TBI model, and improve long term motor and cognitive function after CCI in mice.
The broad long term objective of these studies is to develop novel approaches that
promote axonal preservation and functional recovery after TBI. Completion of these studies will
improve scientific knowledge regarding the role of UCHL1 in neuronal repair and functional
recovery after TBI and test novel TAT-UCHL1 proteins as a novel strategy to address axonal
injury.
弥漫性轴突损伤是运动和认知后遗症的主要组成部分
创伤性脑损伤(TBI)。泛素 C 末端水解酶 L1 (UCHL1) 高表达
神经元中的浓度,可能在轴突运输和突触中发挥重要作用
功能。 UCHL1 的活性对于通过泛素降解异常神经元蛋白非常重要
蛋白酶体途径。因此,UCHL1可能通过以下方式在损伤后的恢复中发挥重要作用:
几种机制。在初步研究中,构建了 TAT-UCHL1 蛋白,该蛋白很容易
腹腔注射时进入大脑TAT-UCHL1 治疗减少了轴突损伤
APP 免疫细胞化学和控制皮质后海马细胞死亡减少
对小鼠的影响(CCI)。鉴定出 UCHL1 152 半胱氨酸处的反应性脂质结合位点
它负责展开和灭活酶。带有一个基因敲入小鼠
构建了 C152A 突变,发现显着减少了轴突损伤,并且
CCI 后运动行为得到改善。携带具有 UCHL1 活性的 C90A 突变的小鼠
还构建了缺乏水解酶活性的。
当前研究的目标是: 1) 确定 UCHL1 C152 位点在
小鼠 CCI 后的轴突损伤、神经元死亡以及运动和认知行为。 2)
确定 UCHL1 水解酶活性在轴突损伤、神经元死亡和神经元死亡中的作用
小鼠 CCI 后的运动和认知行为。 3) 测试是否进行全身治疗
TAT-UCHL1 融合蛋白将减少体外拉伸模型和
体内 TBI 模型,并改善小鼠 CCI 后的长期运动和认知功能。
这些研究的广泛长期目标是开发新方法
促进 TBI 后轴突的保存和功能恢复。完成这些研究将
提高有关 UCHL1 在神经元修复和功能中作用的科学知识
TBI 后恢复并测试新型 TAT-UCHL1 蛋白作为解决轴突的新策略
受伤。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Mutation of a Ubiquitin Carboxy Terminal Hydrolase L1 Lipid Binding Site Alleviates Cell Death, Axonal Injury, and Behavioral Deficits After Traumatic Brain Injury in Mice.
泛素羧基末端水解酶 L1 脂质结合位点的突变可减轻小鼠脑外伤后的细胞死亡、轴突损伤和行为缺陷。
- DOI:
- 发表时间:2021-11-01
- 期刊:
- 影响因子:3.3
- 作者:Mi, Zhiping;Liu, Hao;Rose, Marie E;Ma, Jie;Reay, Daniel P;Ma, Xiecheng;Henchir, Jeremy J;Dixon, C Edward;Graham, Steven H
- 通讯作者:Graham, Steven H
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
C EDWARD DIXON其他文献
C EDWARD DIXON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('C EDWARD DIXON', 18)}}的其他基金
Targeting Cholinergic Deficits with Retinoic Acid after TBI
使用视黄酸治疗 TBI 后的胆碱能缺陷
- 批准号:
10741924 - 财政年份:2023
- 资助金额:
$ 40.47万 - 项目类别:
PRECISE-TBI: PRE Clinical lnteragency research resourcE-TBI
PRECISE-TBI:PRE 临床跨机构研究资源E-TBI
- 批准号:
10935621 - 财政年份:2021
- 资助金额:
$ 40.47万 - 项目类别:
PRECISE-TBI: PRE Clinical lnteragency research resourcE-TBI
PRECISE-TBI:PRE 临床跨机构研究资源E-TBI
- 批准号:
10620688 - 财政年份:2021
- 资助金额:
$ 40.47万 - 项目类别:
PRECISE-TBI: PRE Clinical lnteragency research resourcE-TBI
PRECISE-TBI:PRE 临床跨机构研究资源E-TBI
- 批准号:
10378331 - 财政年份:2021
- 资助金额:
$ 40.47万 - 项目类别:
Connectome Analysis of the Nigrostriatal Neuronal Tract after Blast TBI
冲击波 TBI 后黑质纹状体神经元束的连接组分析
- 批准号:
10015797 - 财政年份:2020
- 资助金额:
$ 40.47万 - 项目类别:
Structural and Functional Dysconnectivity in Dopamine/Acetylcholine Circuitry in Repetitive Mild TBI
重复性轻度 TBI 中多巴胺/乙酰胆碱回路的结构和功能脱节
- 批准号:
9916055 - 财政年份:2020
- 资助金额:
$ 40.47万 - 项目类别:
Multifunctional rehabilitative therapy to reduce Alzheimer pathology after TBI
多功能康复治疗可减少 TBI 后阿尔茨海默病的病理变化
- 批准号:
10063439 - 财政年份:2016
- 资助金额:
$ 40.47万 - 项目类别:
Chronic Lithium Therapy for Traumatic Brain Injury
慢性锂盐治疗创伤性脑损伤
- 批准号:
8591632 - 财政年份:2014
- 资助金额:
$ 40.47万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Deciphering the role of junctional adhesion molecule-A in neutrophil-driven inflammatory response in Alzheimer disease
解读连接粘附分子-A 在阿尔茨海默病中性粒细胞驱动的炎症反应中的作用
- 批准号:
10752753 - 财政年份:2023
- 资助金额:
$ 40.47万 - 项目类别:
Machine Learning Approaches for Behavioral Phenotyping of Humanized Knock-in Models of Alzheimer's Disease
用于阿尔茨海默病人源化敲入模型行为表型的机器学习方法
- 批准号:
10741685 - 财政年份:2023
- 资助金额:
$ 40.47万 - 项目类别:
Exercise-Induced Mitophagy In Hippocampal Neurons Against AD
运动诱导的海马神经元线粒体自噬对抗 AD
- 批准号:
10765466 - 财政年份:2022
- 资助金额:
$ 40.47万 - 项目类别:
Calcineurin activation and scaffolding in A Beta-induced synaptic dysfunction
A Beta 诱导的突触功能障碍中钙调神经磷酸酶的激活和支架
- 批准号:
10668499 - 财政年份:2021
- 资助金额:
$ 40.47万 - 项目类别:
Calcineurin activation and scaffolding in A Beta-induced synaptic dysfunction
A Beta 诱导的突触功能障碍中钙调神经磷酸酶的激活和支架
- 批准号:
10527313 - 财政年份:2021
- 资助金额:
$ 40.47万 - 项目类别: